Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | LTA4H | P09960 | 3/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | BAX | Q07812 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 5/20 | 0.49 |
| ▸ | THRA | P10827 | 4/20 | 0.49 |
| ▸ | PCNA | P12004 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14575001 | 0.91 | THRB (0.54) | MEN1KMT2AESR1ESR2THRB | |
| SCHEMBL2784791 | 0.86 | LTA4H (0.54) | MEN1KMT2ALTA4HNR1H2BAX | |
| SCHEMBL14616574 | 0.83 | THRB (0.49) | MEN1KMT2ATHRBTHRAPCNA | |
| SCHEMBL3957209 | 0.82 | MEN1 (0.70) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL14616573 | 0.81 | MEN1 (0.61) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL24407712 | 0.80 | THRB (0.54) | MEN1KMT2ATHRBTHRAPCNA | |
| SCHEMBL24407715 | 0.78 | THRB (0.52) | MEN1KMT2AESR2THRBTHRA | |
| SCHEMBL13886595 | 0.77 | TAAR1 (0.56) | MEN1KMT2ATHRBTHRAPCNA | |
| SCHEMBL7811939 | 0.76 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL3175106 | 0.76 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220146930-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| US-10220100-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM KEITH R (US) | 2019-03-05 | — | — | US | disclosed |
| US-20180369395-A9 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | LATHAM KEITH R (US) | 2018-12-27 | — | — | US | disclosed |
| US-20180117164-A1 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | LATHAM KEITH R (US) | 2018-05-03 | — | — | US | disclosed |
| US-9144613-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM KEITH R (US) | 2015-09-29 | — | — | US | disclosed |
| US-9125946-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM KEITH R (US) | 2015-09-08 | — | — | US | disclosed |
| EP-2755939-A2 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | Latham, Keith, R. (US) | 2014-07-23 | — | — | EP | disclosed |
| US-20140134105-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LATHAM KEITH R (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140135397-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LATHAM KEITH R (US) | 2014-05-15 | — | — | US | disclosed |
| US-8673269-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM, KEITH | 2014-03-18 | — | — | US | disclosed |
| US-20130022549-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LATHAM, KEITH | 2013-01-24 | — | — | US | disclosed |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| US-20130018026-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| WO-2013010102-A2 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LATHAM KEITH R (US) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018026-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | COMT, GPX4, GPX1 | MEN1 4765/4885KMT2A 3407/4885ESR1 193/4885 |
| US-20140134105-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LPO, AHR, TDO2 | MEN1 4844/4885KMT2A 3314/4885ESR1 901/4885 |
| US-20180369395-A9 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | COMT, GPX4, GPX1 | MEN1 4765/4885KMT2A 3407/4885ESR1 193/4885 |
| US-10220100-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | COMT, GPX4, GPX1 | MEN1 4765/4885KMT2A 3407/4885ESR1 193/4885 |
| US-20180117164-A1 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | COMT, GPX4, GPX1 | MEN1 4765/4885KMT2A 3407/4885ESR1 193/4885 |
| US-20140135397-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | COMT, GPX4, GPX1 | MEN1 4765/4885KMT2A 3407/4885ESR1 193/4885 |
| US-20220146930-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, FGFR1, NHERF1 | MEN1 2209/4885KMT2A 1914/4885ESR1 662/4885 |
| US-20130022549-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LPO, AHR, TDO2 | MEN1 4844/4885KMT2A 3314/4885ESR1 901/4885 |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | TYR, PRDX5, PPARG | MEN1 4824/4885KMT2A 3626/4885ESR1 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.